Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block.
Lena Rivard, Isabelle Nault, Andrew D Krahn...
https://pubmed.ncbi.nlm.nih.gov/37720184/Actively Recruiting
Led by Montreal Heart Institute · Updated on 2026-10-14
250
Participants Needed
10
Research Sites
N/A
Total Duration
Researchers are evaluating whether an electrophysiology EP-based algorithmic approach is better than standard clinical follow-up with 30-day monitoring for patients who develop a new left bundle branch block LBBB after undergoing transcatheter aortic valve implantation TAVI. The study aims to determine if the EP-guided method can reduce the combined risk of syncope, hospitalization, and death. This is a randomized interventional trial sponsored by the Montreal Heart Institute. Participants are randomly assigned to one of two groups. Group 1 undergoes an electrophysiology study before hospital discharge, and if their HV interval is 65 milliseconds or longer, they receive a pacemaker implant. If the electrical slowdown is not confirmed, no pacemaker is implanted. Group 2 patients receive standard care including at least 72 hours of ECG monitoring in the hospital and then transcutaneous cardiac monitoring for 30 days after discharge using a cardiac patch device that continuously records heart rhythms. Throughout the study, participants are closely monitored for cardiovascular hospitalizations, syncope episodes, and death over a 12-month period. The study collects data on emergency visits, hospitalizations, procedural complications, and atrio-ventricular blocks. Devices like electrophysiology catheters and transcutaneous monitors are used to track heart function. Researchers will also assess the cost-effectiveness of the EP-guided approach. Participant involvement includes hospital visits for procedures, continuous heart rhythm monitoring, and follow-up assessments to measure outcomes and safety.
CONDITIONS
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
L
Léna Rivard, MD, MSc
C
Caroline Girard, EP prof.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Montreal Heart Institute
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 12 months
Participants are randomly assigned to either undergo an electrophysiology study with possible pacemaker implantation before hospital discharge or receive standard care with at least 72 hours of ECG monitoring in hospital followed by 30 days of transcutaneous cardiac monitoring.
Hospital visits for procedures and monitoring, plus follow-ups over 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Lena Rivard, Isabelle Nault, Andrew D Krahn...
https://pubmed.ncbi.nlm.nih.gov/37720184/Montreal Heart Institute
Lead Sponsor